Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: Results from a long-term follow up

Haematologica

Volumn 99, Issue 2, 2014, Pages

  Derchi, Giorgio ^a   Balocco, Manuela ^a   Bina, Patrizio ^b   Caruso, Vincenzo ^c   D'Ascola, Domenico G ^d   Littera, Roberto ^e   Origa, Raffaella ^b   Cappellini, Maria D ^f   Forni, Gian L ^a  

^a GALLIERA HOSPITAL   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c ARNAS Garibaldi   (Italy)

^d BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^e Binaghi Hospital   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Pulmonary hypertension; Sildenafil; Thalassemia

Indexed keywords

SILDENAFIL;

CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR PARAMETERS; DEATH; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEART CATHETERIZATION; HUMAN; LETTER; PULMONARY HYPERTENSION; SIX MINUTE WALK TEST; THALASSEMIA; TRICUSPID GRADIENT;

PULMONARY HYPERTENSION; SILDENAFIL; THALASSEMIA;

FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; PIPERAZINES; SULFONES; THALASSEMIA; VASODILATOR AGENTS;

EID: 84896713401     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.095810     Document Type: Letter

References (7)

1. Morris CR, Kim HY, Wood JC, Porter JB, Klings ES, Trachtenberg FL, et al. Sildenafil therapy in thalassemia patients with doppler-defined risk for pulmonary hypertension. Haematologica. 2013 Apr 12. [Epub ahead of print]
2. Derchi G, Galanello R, Bina P, Cappellini MD, Piga A, Lai ME, et al., on behalf of the Webthal®Pulmonary Hypertension Group. Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of a-Thalassemia Patients Using Right Heart Catheterization: a Webthal® Study. Circulation. 2013 Sept 30. [Epub ahead of print]
3. Farmakis D, Aessopos A. Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked. Circulation. 2011;123(11):1227-32.
4. Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, et al. Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353(20):2148-57. Erratum in: N Engl J Med. 2006;354(22):2400-1.
5. Sebkhi A, Strange JW, Phillips SC, Wharton J, Wilkins MR. Phosphodiesterase type 5 as a target for the treatment of hypoxiainduced pulmonary hypertension. Circulation. 2003;107(25):3230-5.
6. Littera R, La Nasa G, Derchi G, Cappellini MD, Chang CY, Contu L. Long-term treatment with sildenafil in a thalassemic patient with pulmonary hypertension. Blood. 2002;100(4):1516-7.
7. Derchi G, Forni GL, Formisano F, Cappellini MD, Galanello R, D'Ascola G, et al. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies. Haematologica. 2005;90(4):452-8.